Nature's Sunshine Products (NATR) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
2 Dec, 2025Executive summary
The 2025 Annual Meeting will be held on April 30, 2025, with shareholders voting on director elections, executive compensation, and auditor ratification.
2024 net sales reached $454.4 million, net income was $7.9 million, and adjusted EBITDA was $40.3 million.
Shareholder materials are available online, and voting is encouraged either in advance or in person.
Voting matters and shareholder proposals
Shareholders will elect eight directors, vote on a non-binding say-on-pay resolution, and ratify Deloitte & Touche LLP as the independent auditor.
The Board recommends voting for all proposals.
Shareholder proposals for the 2025 meeting are closed; proposals for 2026 must be submitted by November 20, 2025.
Board of directors and corporate governance
The Board consists of ten members, with nine being independent; average tenure is over four years.
Directors serve one-year terms, with annual elections and plurality voting.
The Board has four standing committees: Audit, Compensation, Governance, and Risk Management, all chaired by independent directors.
Board refreshment is supported by age and term limits, and a new independent Chair will be selected after the 2025 meeting.
Stock ownership guidelines require directors to hold shares worth at least three times the annual equity grant value.
Latest events from Nature's Sunshine Products
- Record sales and EBITDA growth in 2025 driven by digital and global expansion.NATR
Q4 202510 Mar 2026 - Digital-first growth, premium products, and omni-channel reach drive strong financial outlook.NATR
Small-Cap Growth Virtual Investor Conference3 Feb 2026 - Q2 2024 sales and earnings declined, but cash and digital investments remain strong.NATR
Q2 20242 Feb 2026 - Q3 2025 saw record sales, margin expansion, and raised outlook on digital and Asia-Pacific strength.NATR
Q3 202529 Jan 2026 - Digital-first strategy and premium products drive growth and strong financial performance.NATR
2024 Annual Gateway Conference22 Jan 2026 - Q3 net sales up 3.1%, net income rose, and guidance increased on Asia and Europe strength.NATR
Q3 202415 Jan 2026 - Premium supplement brand drives global growth with digital, innovation, and margin expansion plans.NATR
2024 Southwest IDEAS Conference12 Jan 2026 - Q4 net sales up 8.5% to $118.2M; 2025 outlook cautious with $445–$470M sales guidance.NATR
Q4 202427 Dec 2025 - 2,854,607 shares registered for resale; no proceeds to issuer; global direct selling focus.NATR
Registration Filing16 Dec 2025